# Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA

> **NCT03453424** · PHASE2,PHASE3 · COMPLETED · sponsor: **South Egypt Cancer Institute** · enrollment: 90 (actual)

## Conditions studied

- Abdominal Pain
- Abdominal Cancer

## Interventions

- **PROCEDURE:** TEA+DEX
- **PROCEDURE:** TEA

## Key facts

- **NCT ID:** NCT03453424
- **Lead sponsor:** South Egypt Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-30
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03453424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03453424, "Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03453424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*